株式会社センノ・セラピューティクス
ActiveヒトiPS細胞由来の肝前駆細胞を活用した急性肝不全に対する細胞治療の開発
Its site says now · captured 2026-08-23
SENNO THERAPEUTICS
Senno Therapeutics は、ヒトiPS細胞由来肝前駆細胞および肝臓オルガノイドの技術を用いて、致死的な肝不全に対する新たな治療法の開発を行うバイオベンチャーです。
Next to it in Healthcare and bio · iPSC-derived cell therapy for acute liver failure
- iOrgan BioSOSV SOSV IndieBio NY 2025 H2
Supplying Cells to Improve the Human Condition
- Tinkeso TherapeuticsSOSV SOSV IndieBio NY 09
Cell therapy for oncology and autoimmune diseases.
- Modulari-TY Combinator W23
We teach your immune system to attack and cure cancer
- Cell BioEnginesSOSV SOSV IndieBio NY 06
'Off-the-shelf' Curative Cell Therapies
- Eugit TherapeuticsY Combinator S22
Enabling Tissue Targeting of Therapies
- AGED DiagnosticsPlug and Play PnP 2025
AGED (Active Genomes Expressed) Diagnostics is developing accurate, non-invasive blood tests for early liver disease detection.
- Omnispirant LimitedPlug and Play PnP 2025
OmniSpirant develops regenerative gene therapies with game changing innovation in respiratory medicine and oncology.
- Guardian BioY Combinator S22
Dendritic cell-based platform for cancer therapy